Recro Pharma, Inc. (REPH)

Last Price: 4.46 (2020-07-06)

Company Description

Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $99.22M
Net Income (Most Recent Fiscal Year) $-18.63M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 1.13
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 8.03
Pre-Tax Margin (Trailing 12 Months) -3.40%
Net Margin (Trailing 12 Months) -25.38%
Return on Equity (Trailing 12 Months) -15.25%
Return on Assets (Trailing 12 Months) -2.39%
Current Ratio (Most Recent Fiscal Quarter) 6.14
Quick Ratio (Most Recent Fiscal Quarter) 4.86
Debt to Common Equity (Most Recent Fiscal Quarter) --
Inventory Turnover (Trailing 12 Months) 4.42
Book Value per Share (Most Recent Fiscal Quarter) $-0.30
Earnings per Share (Most Recent Fiscal Quarter) $-0.33
Earnings per Share (Most Recent Fiscal Year) $0.20
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Common Shares Outstanding 23.57M
Free Float 18.12M
Market Capitalization $108.40M
Average Volume (Last 20 Days) 0.42M
Beta (Past 60 Months) 0.81
Percentage Held By Insiders (Latest Annual Proxy Report) 23.10%
Percentage Held By Institutions (Latest 13F Reports) 63.69%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%